Monopar Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MNPR and other ETFs, options, and stocks.About MNPR
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages.
CEOChandler Drew Robinson
CEOChandler Drew Robinson
Employees16
Employees16
HeadquartersWilmette, Illinois
HeadquartersWilmette, Illinois
Founded2014
Founded2014
Employees16
Employees16
MNPR Key Statistics
Market cap194.89M
Market cap194.89M
Price-Earnings ratio-8.01
Price-Earnings ratio-8.01
Dividend yield—
Dividend yield—
Average volume25.13K
Average volume25.13K
High today$33.22
High today$33.22
Low today$31.17
Low today$31.17
Open price$33.22
Open price$33.22
Volume14.46K
Volume14.46K
52 Week high$54.30
52 Week high$54.30
52 Week low$1.72
52 Week low$1.72
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own MNPR. This list is generated using Robinhood data, and it’s not a recommendation.